Cite

HARVARD Citation

    Ciccarese, C. et al. (2021). Efficacy of VEGFR-TKIs plus immune checkpoint inhibitors in metastatic renal cell carcinoma patients with favorable IMDC prognosis. Cancer treatment reviews. p. . [Online]. 
  
Back to record